BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 29325985)

  • 21. Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia.
    Arepally G; Reynolds C; Tomaski A; Amiral J; Jawad A; Poncz M; Cines DB
    Am J Clin Pathol; 1995 Dec; 104(6):648-54. PubMed ID: 8526207
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Overdiagnosis of heparin-induced thrombocytopenia in surgical ICU patients.
    Berry C; Tcherniantchouk O; Ley EJ; Salim A; Mirocha J; Martin-Stone S; Stolpner D; Margulies DR
    J Am Coll Surg; 2011 Jul; 213(1):10-7; discussion 17-8. PubMed ID: 21531584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical effectiveness of a Bayesian algorithm for the diagnosis and management of heparin-induced thrombocytopenia.
    Raschke RA; Gallo T; Curry SC; Whiting T; Padilla-Jones A; Warkentin TE; Puri A
    J Thromb Haemost; 2017 Aug; 15(8):1640-1645. PubMed ID: 28622439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of whole blood impedance aggregometry as a new diagnostic tool for HIT: results of a large Australian study.
    Morel-Kopp MC; Tan CW; Brighton TA; McRae S; Baker R; Tran H; Mollee P; Kershaw G; Joseph J; Ward C;
    Thromb Haemost; 2012 Mar; 107(3):575-83. PubMed ID: 22234599
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Frequency of heparin-induced thrombocytopenia in critical care patients.
    Verma AK; Levine M; Shalansky SJ; Carter CJ; Kelton JG
    Pharmacotherapy; 2003 Jun; 23(6):745-53. PubMed ID: 12820817
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence and risk of preexisting heparin-induced thrombocytopenia antibodies in patients with acute VTE.
    Warkentin TE; Davidson BL; Büller HR; Gallus A; Gent M; Lensing AWA; Piovella F; Prins MH; Segers AEM; Kelton JG
    Chest; 2011 Aug; 140(2):366-373. PubMed ID: 21393394
    [TBL] [Abstract][Full Text] [Related]  

  • 28. FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia.
    Nazi I; Arnold DM; Smith JW; Horsewood P; Moore JC; Warkentin TE; Crowther MA; Kelton JG
    J Thromb Haemost; 2013 Jun; 11(6):1146-53. PubMed ID: 23551961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fondaparinux treatment of acute heparin-induced thrombocytopenia confirmed by the serotonin-release assay: a 30-month, 16-patient case series.
    Warkentin TE; Pai M; Sheppard JI; Schulman S; Spyropoulos AC; Eikelboom JW
    J Thromb Haemost; 2011 Dec; 9(12):2389-96. PubMed ID: 21883878
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective, blinded study of a PF4-dependent assay for HIT diagnosis.
    Samuelson Bannow B; Warad DM; Jones CG; Pechauer SM; Curtis BR; Bougie DW; Sharma R; Grill DE; Redman MW; Khalighi PR; Leger RR; Pruthi RK; Chen D; Sabath DE; Aster RH; Garcia DA; Padmanabhan A
    Blood; 2021 Feb; 137(8):1082-1089. PubMed ID: 32898858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The 4Ts scoring system for heparin-induced thrombocytopenia in medical-surgical intensive care unit patients.
    Crowther MA; Cook DJ; Albert M; Williamson D; Meade M; Granton J; Skrobik Y; Langevin S; Mehta S; Hebert P; Guyatt GH; Geerts W; Rabbat C; Douketis J; Zytaruk N; Sheppard J; Greinacher A; Warkentin TE;
    J Crit Care; 2010 Jun; 25(2):287-93. PubMed ID: 20149589
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Serotonin release assay (SRA)-negative HIT, a newly recognized entity: Implications for diagnosis and management.
    Pandya KA; Johnson EG; Davis GA; Padmanabhan A
    Thromb Res; 2018 Dec; 172():169-171. PubMed ID: 30419472
    [No Abstract]   [Full Text] [Related]  

  • 33. Quantitative interpretation of optical density measurements using PF4-dependent enzyme-immunoassays.
    Warkentin TE; Sheppard JI; Moore JC; Sigouin CS; Kelton JG
    J Thromb Haemost; 2008 Aug; 6(8):1304-12. PubMed ID: 18489711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole blood impedance aggregometry detects heparin-induced thrombocytopenia antibodies.
    Morel-Kopp MC; Aboud M; Tan CW; Kulathilake C; Ward C
    Thromb Res; 2010 May; 125(5):e234-9. PubMed ID: 20053425
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical Significance of the Serotonin Release Assay and Platelet Count Monitoring After Cardiac Surgery.
    Motohashi S; Matsuo T; Inoue H; Kaneko M; Shindo S
    Clin Appl Thromb Hemost; 2018 Sep; 24(6):944-949. PubMed ID: 29046071
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Anti-PF4-heparin immunoglobulin G is the major class of heparin-induced thrombocytopenia antibody: findings of an enzyme-linked immunofiltration assay using membrane-bound hPF4-heparin.
    Vun CM; Evans S; Chesterman CN
    Br J Haematol; 2001 Jan; 112(1):69-75. PubMed ID: 11167786
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin-induced thrombocytopenia.
    Greinacher A; Fürll B; Selleng S
    Methods Mol Biol; 2013; 992():301-18. PubMed ID: 23546723
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence and clinical implications of anti-PF4/heparin antibodies in intensive care patients: a prospective observational study.
    Selleng S; Selleng K; Friesecke S; Gründling M; Kuhn SO; Raschke R; Heidecke OJ; Hinz C; Hron G; Warkentin TE; Greinacher A
    J Thromb Thrombolysis; 2015 Jan; 39(1):60-7. PubMed ID: 25002339
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Murine monoclonal antibody to platelet factor 4/heparin complexes as a potential reference standard for platelet activation assays in heparin-induced thrombocytopenia.
    Asada R; Wanaka K; Walenga J; Prechel M; Miyashita K; Escalante V; Kaneko C; Hoshino N; Oosawa M; Matsuo M
    Clin Appl Thromb Hemost; 2013; 19(1):37-41. PubMed ID: 22826445
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of platelets by heparin-induced thrombocytopenia antibodies in the serotonin release assay is not dependent on the presence of heparin.
    Prechel MM; McDonald MK; Jeske WP; Messmore HL; Walenga JM
    J Thromb Haemost; 2005 Oct; 3(10):2168-75. PubMed ID: 16150048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.